Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Up 121.2% in February

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,039,200 shares, an increase of 121.2% from the February 13th total of 469,800 shares. Based on an average daily trading volume, of 200 shares, the days-to-cover ratio is currently 5,196.0 days. Currently, 0.5% of the shares of the stock are sold short.

Recordati Industria Chimica e Farmaceutica Stock Performance

OTCMKTS:RCDTF opened at $55.54 on Friday. The company has a market capitalization of $11.46 billion, a price-to-earnings ratio of 27.77 and a beta of 0.30. The company has a 50-day moving average of $55.54 and a 200-day moving average of $53.47. Recordati Industria Chimica e Farmaceutica has a 52 week low of $52.25 and a 52 week high of $52.25.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.